Gelteq Limited
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Gelteq Limited and other ETFs, options, and stocks.About GELS
Gelteq Ltd. operates as a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products.
CEONathan J. Givoni
CEONathan J. Givoni
Employees18
Employees18
HeadquartersMelbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded2017
Founded2017
Employees18
Employees18
GELS Key Statistics
Market cap11.68M
Market cap11.68M
Price-Earnings ratio-2.98
Price-Earnings ratio-2.98
Dividend yield—
Dividend yield—
Average volume5.99M
Average volume5.99M
High today$1.12
High today$1.12
Low today$1.03
Low today$1.03
Open price$1.10
Open price$1.10
Volume56.93K
Volume56.93K
52 Week high$5.50
52 Week high$5.50
52 Week low$0.7701
52 Week low$0.7701
Stock Snapshot
Gelteq Limited(GELS) stock is priced at $1.08, giving the company a market capitalization of 11.68M. It carries a P/E multiple of -2.98.
On 2025-12-05, Gelteq Limited(GELS) stock traded between a low of $1.03 and a high of $1.12. Shares are currently priced at $1.08, which is +4.9% above the low and -3.3% below the high.
The Gelteq Limited(GELS)'s current trading volume is 56.93K, compared to an average daily volume of 5.99M.
In the last year, Gelteq Limited(GELS) shares hit a 52-week high of $5.50 and a 52-week low of $0.77.
In the last year, Gelteq Limited(GELS) shares hit a 52-week high of $5.50 and a 52-week low of $0.77.
People also own
Based on the portfolios of people who own GELS. This list is generated using Robinhood data, and it’s not a recommendation.